SCHEMBL3568322

SCHEMBL3568322

CN1CCN=C1c1ccc(NC(=O)C(CC(=O)N2CCOCC2)N(C(N)=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 4/20 0.39
F2 P00734 1/20 0.39
KCNH2 Q12809 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
ADRB2 P07550 1/20 0.37
EPHX2 P34913 2/20 0.37
POLB P06746 2/20 0.37
ALDH1A1 P00352 1/20 0.36
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
PIK3CG P48736 1/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP3A4 P08684 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3571727 0.93 F10 (0.38) F10ADRB2POLBALDH1A1
SCHEMBL3569863 0.92 ALDH1A1 (0.38) F10ADRB2POLBALDH1A1
SCHEMBL3563906 0.88 F10 (0.40) F10TP53
SCHEMBL3562609 0.87 F10 (0.40) F10MEN1KMT2A
SCHEMBL3557893 0.86 F10 (0.39) F10
SCHEMBL3569851 0.86 F10 (0.39) F10KDM4ETP53
SCHEMBL3564282 0.83 F10 (0.39) F10POLBCNR1
SCHEMBL3574011 0.82 F10 (0.39) F10TP53
SCHEMBL3563374 0.82 F10 (0.39) F10TP53
SCHEMBL3568325 0.82 F10 (0.49) F10F2KCNH2SMN1; SMN2ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678913-B2 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2010-03-16 US claimed
US-20060160821-A1 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2006-07-20 US claimed
US-7678913-B2 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2010-03-16 US disclosed
US-20060160821-A1 Ureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2006-07-20 US disclosed
WO-2006063113-A2 UREAS AS FACTOR XA INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160821-A1 Ureas as factor Xa inhibitors TFPI, F12, F11 F10 9/4885F2 6/4885KCNH2 2754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.